Investigative Sites

Latest News


i11424263034630.gif

The organization of healthcare is changing rapidly. The healthcare delivery system is increasingly powered by payers and regulators, and this directs both clinical medicine and drug development. Partly because of this change, the drug development process has been heavily scrutinized, and a great emphasis has been placed on more efficient translation of basic science into useful medicines.

i1-2.gif

After a five-year review of clinical trial quality measurement research and practices, we have concluded that clinical trial quality measurement does not meet current scientific standards

Recruitment Roles

Sponsors, CROs, and investigator sites must all work together for effective patient recruitment.

Research sponsors and the research community must solve the inefficiency and redundancy that plagues the ethics review system.

Why are some contract research organizations, sponsors, and other research facilities not pursuing accreditation?

PC14223_articlerailheader-706505-1408628830638.jpg

Monitoring of clinical trials is a federally mandated responsibility of trial sponsors and a core offering of contract research organizations (CROs) that is crucial to the validity of clinical research.